Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Limited has issued a Postal Ballot Notice (voting from 24th July to 22nd August 2025) seeking shareholder approval on 6 resolutions. Two are ordinary resolutions for continuation of Mr. Ramesh Vangal as Non-Executive Chairman and Mr. Anand Subramanian as Non-Executive, Non-Independent Director. A special resolution seeks appointment of Mr. Saif Khan as Independent Director for a 5-year term (June 2025 to June 2030). Another special resolution proposes raising the company's overall borrowing limit from ₹100 crores to ₹250 crores (replacing the 2017 AGM approval). Two ordinary resolutions seek approval for material related party transactions — up to ₹70 crores with Katra Holding Pvt Ltd and up to ₹35 crores with Katra Phytochem (India) Pvt Ltd — spread over FY26 to FY30, covering unsecured borrowings, buying/selling products, and services. The backdrop includes termination of liquidation proceedings against promoter Katra Holdings Ltd by the Mauritius Supreme Court in May 2025, and an ongoing NCLT petition that had earlier put director-related resolutions in abeyance.
Shareholders will decide on board continuity, a new independent director, a 2.5x jump in borrowing capacity, and significant related-party transactions over the next five years. The higher borrowing ceiling and large RPT approvals with promoter-group entities (Katra Holding and Katra Phytochem) could increase leverage and related-party exposure, so shareholder scrutiny on these items is warranted.